Sun Pharma acquires Pola Pharma-Japan
Sun Pharma has completed acquisition of Pola Pharma – a Japanese pharma company to strengthen its presence in dermatology segment across the globe. The company […]
sunpharma
Sun Pharma launches Kapspargo Sprinkle in US markets
Sun Pharma has launched Kapspargo Sprinkle (metoprolol succinate) extended-release capsules in the US markets. The drug is used for the treatment of hypertension (to lower […]
Sun Pharma receives USFDA approval for tildrakizumab
Sun Pharmaceutical Industries has received USFDA approval for the drug tildrakizumab-asmn which is used for the treatment of adults with moderate-to-severe plaque psoriasis who are […]
Sun Pharmaceuticals receives USFDA approval for BromSite
Sun Pharmaceutical Industries has received final USFDA approval for its non-steroid drug BromSite used to treat inflammation and prevent pain in patients undergoing cataract surgery. […]
Sun Pharma receives USFDA approval for XiminoTM
Sun Pharmaceutical Industries has received approval from USFDA for its new drug used for acne treatment XiminoTM extended-release capsules in strengths of 45 mg, 90 […]